Currently, limited information is available regarding the correlation between Myc overexpression and response to PD-1/PD-L1 inhibitors in tumors such as B cell non-Hodgkin lymphomas. This evidence concerns the gene CD274 and B-cell non-Hodgkin lymphoma.